Rajan Merchant, MD, the lead investigator of the trial recently presented a paper at the National Asthma and Allergy Association meeting in Washington, DC. The findings of the study, though still preliminary, confirm the use of GPS enabled wireless inhalers improve asthma care, and results in savings for the patient.
As the study moves forward, Dr. Merchant will continue to provide updates in regards to actual financial savings per patient at academic conferences.
Dr. Merchant’s presentation has been featured on a number of websites and news services, please click on the links below the articles:
Medscape
Fast Company
In addition, Dr. Merchant was recently featured on the CBS National News.
Publish date:
Friday, December 13, 2013
Media Contacts:
William Hodges, Director of External Communications
[email protected]
Lindsay Leszczynski, External Communications Manager
[email protected]